Coherus BioSciences Inc is a late-stage clinical biologics platform company. The Company is engaged in developing biosimilar therapeutics.
| Website: | www.coherus.com |
| Main Phone: | +1 650 649-3530 |
| Address: | 333 Twin Dolphin Drive |
| Address 2: | Suite 600 |
| State: | CA |
| City / Town: | Redwood City |
| Country: | USA |
| Postal Code: | 94065 |
| Exchange: | NSD |
| Employees: | 115 |
| NAICS: | 541711 |
| Last Price 15.65 | Change $ -0.15 | Change % -0.95 | Tick N/A |
| Bid 13.15 | Bid Size 100.00 | Ask N/A | Ask Size 0.00 |
| Open 15.90 | High 16.08 | Low 15.55 | Prev Close 15.80 |
| Last Trade | Volume 1.1 mi | 52 Wk Hi 31.98 | 52 Wk Low 14.00 |
| Market Cap 802.7 mi | Ex-Div Date N/A | Div Rate N/A | Yield N/A |
| Shares 51,288,117.00 | EPS (TTM) -3.38 | PE Ratio N/A | Exchange NSD |
|
|
|
|
| Last 3 Mo | Last 12 Mo | |
|---|---|---|
| Number of Insider Trades | 17 | 47 |
| Number of Buys | 7 | 15 |
| Number of Sells | 10 | 32 |
| Net Activity | -17908 | -32868 |
| Last 10 Buys | Shares |
|---|---|
| N/A | 0 |
| Last 10 Sell | Shares |
|---|---|
| Peter K. Watler | 1,000 |
| Peter K. Watler | 1,000 |
| Alan C. Herman | 1,000 |
| Peter K. Watler | 1,000 |
| Peter K. Watler | 1,000 |
| Peter K. Watler | 1,000 |
| Peter K. Watler | 1,000 |
| Peter K. Watler | 1,000 |
| Alan C. Herman | 1,000 |
| Alan C. Herman | 1,000 |
| Current | 1 Week Ago | 2 Weeks Ago | 3 Weeks Ago | |
|---|---|---|---|---|
| High Target Price Estimate | 46 | 46 | 46 | 46 |
| Low Target Price Estimate | 45 | 45 | 45 | 45 |
| Mean Target Price Estimate | 45.5 | 45.5 | 45.5 | 45.5 |
| Standard Deviation | 0.71 | 0.71 | 0.71 | 0.71 |
| Date of Most Recent Estimate | 08/11/16 | 06/07/16 | 06/07/16 | 08/11/16 |
| Form Type | Form Description | Pages | Date |
|---|---|---|---|
| S-8 | Securities offered to employees under employee benefit plans | 11 | 2016-08-11 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2016-08-10 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2016-08-10 |
| 10-Q | Quarterly report with a continuing view of a company's financial position | 127 | 2016-08-09 |
| 8-K | Report of unscheduled material events or corporate changes. | 14 | 2016-08-09 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2016-08-08 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2016-08-03 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2016-07-25 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2016-07-22 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2016-07-13 |
| Current | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
|---|---|---|---|---|
| Strong Buy | 2 | 3 | 3 | 3 |
| Moderate Buy | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 |
| Moderate Sell | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 |
| Mean Rec. | 1 | 1 | 1 | 1 |
© 2017 Equities
* All dates and time are being displayed in Eastern Standard Time (EST).
